Changes in Cerebrovascular Resistance with Hypertension and Telmisartan Treatment in Tg2576 mice
Angiotensin receptor blockers (ARBs) may slow hypertension-induced cerebrovascular changes in Alzheimer’s disease (AD). We measured cerebrovascular resistance (CVR) during hypertension and ARB treatment in AD mice. Hypertension increased CVR with minimal ARB treatment effects.
Authors
- Mark Fisher (ORCID: https://orcid.org/0000-0001-9802-8826)
- David H. Cribbs (ORCID: https://orcid.org/0000-0002-6870-4480)
- Christian Crouzet (ORCID: https://orcid.org/0000-0002-8809-2119)
- Kim N. Green (ORCID: https://orcid.org/0000-0002-6049-6744)
- Noé Rubén Chávez (ORCID: https://orcid.org/0000-0002-7768-0388)
- Danny F. Xie (ORCID: https://orcid.org/0000-0001-9838-5268)
- Natalie M. Johnson (ORCID: https://orcid.org/0000-0001-8584-9713)
- Bernard Choi (ORCID: https://orcid.org/0000-0002-4380-8291)
- Jihua Liu (ORCID: https://orcid.org/0000-0003-2908-9160)
- Han Liu (ORCID: https://orcid.org/0000-0001-7940-4339)
- Thinh Phan
Institutions
- University of California, Irvine (US)
- Beckman Laser Institute and Medical Clinic (US)
Publication Details
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1364/brain.2025.bw2b.3
- Primary Topic
- Optical Imaging and Spectroscopy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00